New Clinical Trial Announced For Break Through Cancer Pain

Exodon LLC, a leading international clinical research company, announces the start of a new clinical trial for break through cancer pain (BTCP). The clinical trial will be is being conducted by Archimedes Development, Ltd. Exodon is currently recruiting patients suffering from break through cancer related pain (BTCP). The focus of this clinical trial is to study the efficacy of a new nasal formation of an on-the-market opioid for BTCP. [click link for full article]

More: continued here

Filed under: Clinical Trials on October 25th, 2007